In contrast to LDL, high-density lipoproteins (HDLs) exert vasculoprotective actions; in addition to cellular cholesterol efflux and anti-oxidative/anti-inflammatory properties, HDLs protect endothelial cells from the cytotoxicity of oxLDL
. Moreover, HDLs decrease endothelial cell apoptosis induced by mildly oxLDL [7] , tumour necrosis factor-␣ (TNF-␣) [8] and growth factor deprivation [9] . HDLs equally protect endothelial cells from necrosis [10, 11] .
Both apolipoprotein and lipid components appear to contribute to the cytoprotective properties of HDL; these primarily include apolipoprotein A-I (apoA-I), the major HDL apolipoprotein [7, 8] , and sphingosine-1-phosphate (S1P), a minor bioactive lipid [10] [11] [12] . Gene transfer of human apoA-I to rats has been recently shown to decrease apoptosis in cardiomyocytes [13] . [14, 15] . S1P circulates at high nanomolar concentrations primarily associated with small, dense HDL 3 [16] [17] [18] , and is likely derived from red blood cells and/or platelets [19, 20] . Equally, S1P can function as a ligand for G protein-coupled S1P receptors on endothelial and smooth muscle cells, thereby enhancing cell growth and survival [21] . Consistent with these findings, intracellular signal transduction induced by HDL associated lysosphingolipids, primarily S1P, may in part account for the cytoprotective effects of HDL [22] .
Plasma membrane receptors and transporters involved in cellular cholesterol efflux, including scavenger receptor class B type I (SR-BI) and ATP-binding cassette transporters A1 (ABCA1) and G1 (ABCG1), may potentially mediate the cytoprotective effects of HDL via their interaction with apoA-I and ensuing cellular efflux of toxic oxidized lipids
HDL particles are highly heterogeneous in their structure, physicochemical properties, intravascular metabolism and anti-atherogenic and vasculoprotective activities. Small, dense, protein-rich HDL 3 display elevated capacities to accept cellular cholesterol [23] , to inhibit expression of adhesion molecules [24] and to protect LDL from oxidation [25] as compared to large, light, lipid-rich HDL 2 [26] . Our recent data suggest that small, dense HDL 3 enriched in S1P [18] exert potent protection of endothelial cells from primary apoptosis induced by mild oxLDL [27] ; however, HDL components involved in such cytoprotection remain indeterminate. We suggested that apoA-I and/or S1P constitute major factors in the anti-apoptotic activity of small HDL. We present evidence that apoA-I is pivotal to the potent protection of endothelial cells against primary apoptosis induced by mild oxLDL; by contrast, S1P failed to enhance HDL and/or apoA-Imediated cytoprotection. [28] [29] [30] [5-7, 31, 32] .
Methods

To investigate cytoprotective effects of HDL subfractions, we employed human microvascular endothelial cells (HMEC-1) which are widely used for in vitro studies of multiple biological aspects of atherosclerosis, including inflammation and apoptosis
Cellular apoptotic and necrotic morphology was determined microscopically using two vital fluorescent dyes, a permeant intercalating green probe SYTO-13 and a non-permeant intercalating orange probe propidium iodide (PI) [33] . Apoptosis and necrosis were equally quantified using the annexin V-flourescein isothiocyanate (FITC)/PI kit for flow cytometry (Beckman Coulter, Roissy, France) .
Lipoproteins were preparatively fractionated by isopycnic density gradient ultracentrifugation from normolipidemic human serum or ethylenediaminetetraacetic acid plasma as previously described [34, 35] [36] ) and selectively induces apoptosis in endothelial cells [31] [25] , endothelial cell culture [37] , characterization of apoptosis [37] , S1P assays [18] and statistical analysis are available as an online supplement.
Results
HDL mediated protection of HMEC-1 from oxLDL-induced cytotoxicity
Progressive reduction in HDL hydrated density and size across HDL particle subfractions from HDL 2b to HDL 3c was associated with progressive elevation in protein content and diminution in lipid content (Table S1 ). Consistent with earlier data [25] (Fig. 1B) , total HDL mass (Fig. 1C) or the number of HDL particles (Fig. 1D) Fig. 2A and (Fig. 3C) ; all HDL subfractions attenuated DNA fragmentation induced by mildly oxLDL, with small dense HDL 3c providing most potent protection (Fig. 3C ). [39] .
HDL mediated protection of HMEC-1 from oxLDL-induced apoptosis
Death of HMEC-1 endothelial cells treated with mildly oxLDL (200 g apoB-100/ml; 4-13 mol of conjugated dienes/mol LDL) occurred mainly through an apoptotic process, as indicated by the number of cells exhibiting characteristic morphological nuclear changes, such as chromatin condensation and nuclear fragmentation clearly visualized by SYTO13/IP labelling (
B). It is of note that oxLDL induced the appearance of cells exhibiting fragmented nuclei, which were permeable to PI, a vital DNA marker excluded from intact nuclei and indicative of a late stage of apoptosis (post-apoptotic necrotic patterns). By contrast, the level of primary necrosis was very low (Ͻ5%) as shown by low levels of lactate dehydrogenase (LDH) release and by small numbers of PI-stained cells with the morphological features of primary necrosis (data not shown). All HDL subfractions protected HMEC-1 from apoptosis induced by oxLDL, attenuating condensed chromatin staining by SYTO-13 and post-apoptotic nuclear staining by PI; again however, small dense HDL 3c revealed superior cytoprotection relative to less dense HDL subfractions (Fig. 2C-G). Apoptosis and necrosis were equally quantified by flow cytometry as cellular binding of annexin V; indeed, annexin V specifically interacts with phosphatidylserine in the extracellular membrane leaflet of apoptotic cells [38]. Preincubation with small, dense HDL 3b and -3c (-54%
,
Fig 2. HDL subfractions protect HMEC-1 from oxLDL-induced apoptosis. Apoptotic and necrotic morphology was evaluated using fluorescent microscopy either in the absence of added lipoproteins (A), or in the presence of oxLDL added after preincubation in the absence (B) or in the presence of HDL 2b (C), 2a (D), 3a (E), 3b (F) and 3c (G) subfractions. Normal nuclei, loose chromatin staining by SYTO-13 (green); apoptotic nuclei, condensed chromatin staining by SYTO-13 (green) and/or chromatin fragmentation; post-apoptotic necrosis, nuclear staining by PI (orange)
OxLDL induced cytoplasmic release of cytochrome c and AIF from HMEC-1, and degradation of Bid (Fig. 4) . Preincubation of cells with small dense HDL 3c reversed this cascade of pro-apoptotic events, whereas large, light HDL 2b was markedly less effective (Fig. 4) . (Fig. 5) . (Fig. 6A) . ROS production was also blocked by the antioxidants Trolox and pyrolidine dithiocarbamate employed (Fig. 6B) . Interestingly, longer incubations of HMEC-1 with oxLDL were characterized by progressive decrease in intracellular nitric oxide concentrations, consistent with previous reports on the effects of oxLDL on nitric oxide production in vascular and macrophagic cells [40] . In order to investigate whether nitric oxide contributed to the increase in intracellular ROS induced by oxLDL, we measured the oxidation of H2DCFDA in the presence of L-NAME. As shown in Fig. 6, C 
HDL mediated protection of HMEC-1 from oxLDL-induced generation of reactive oxygen species (ROS)
Since H2DCFDA does not allow to identify individual ROS, we subsequently determined the source of intracellular ROS generated by oxLDL using a series of specific inhibitors for NAD(P)H oxidases (diphenylene iodonium and apocynin), xanthine oxidase (allopurinol), mitochondrial electron transport chain (ETC) at a level of complex I (rotenone) and complex III (myxothiazol), cytochrome P450 (sulfaphenazole) and metabolism of arachidonic acid (eicosatetraynoic acid for lipoxygenase and indomethacine for cyclooxygenase). We found that NAD(P)H oxidase inhibitors diphenylene iodonium and apocynin as well as the complex III inhibitor myxothiazol potently inhibited intracellular ROS increase elicited by oxLDL
Role of apolipoproteins in the anti-apoptotic effects of HDL subfractions
The particle content of apoA-I fell progressively with HDL size from 4.3 mol/mol in HDL 2b to 2.9 mol/mol in HDL 3c (Table S1) 
ml). Importantly, no S1P was co-isolated with the protein fraction as verified by HPLC (data not shown).
Fig 4. HDL subfractions protect HMEC-1 against oxLDL-induced cytoplasmic release of cytochrome c and AIF and degradation of Bid. HMEC-1 were plated in Petri dishes, pre-incubated in the absence (control) or in the presence of each HDL subfraction (25 g total protein/ml) for 24 hrs and subsequently incubated with oxLDL for 16 hrs. Following cellular homogenisation, cytosolic proteins were immunoblotted in the mitochondria free-cytosol using anti-cytochrome c (A), anti-AIF (B) and anti-Bid (C) monoclonal antibodies, and equally using anti ␤-actin antibody to detect ␤-actin as a housekeeping protein. Data are scaled to the highest ratio of the protein of interest to
SR-BI is a major apoA-I-binding HDL receptor on human endothelial cells [42]; we therefore additionally evaluated the potential role of SR-BI in mediating the cytoprotective effects of HDL subfractions against oxLDL. Preincubation of HMEC-1 with a monoclonal antibody to human SR-BI did not influence the toxicity of oxLDL (MTT reduction of 42% and 40% of control levels in the absence and presence of the antibody; n ϭ 2). By contrast, the antibody markedly diminished (up to -68%) the protective effects of HDL 3c (MTT reduction of 82 Ϯ 5 and 53 Ϯ 4% of control levels in the absence and presence of the antibody; n ϭ 3). No effect on the cytoprotective activity of HDL 3c was observed when HMEC-1 were pre-incubated with an irrelevant antibody (data not shown).
Role of S1P in the anti-apoptotic effects of HDL subfractions S1P was asymmetrically distributed across the HDL particle spectrum, with preferential enrichment in HDL 3 as compared to HDL 2 [18] (Fig. 7A) 
. Indeed, S1P was 3-fold enriched in HDL 3c and 3b (approximately 1 mole per 17 HDL particles) as compared to HDL 2b (approximately 1 mole per 50 HDL particles). HDL molar
The potential contribution of S1P to the capacity of HDL subfractions to inhibit oxLDL-induced apoptosis in HMEC-1 was then evaluated in four in vitro experimental systems, involving (i) reconstituted HDL (rHDL) discs containing S1P, (ii) S1P in the presence of bovine serum albumin (BSA), (iii) S1P enrichment of HDL subfractions and (iv) use of a pharmacological inhibitor to ligate S1P1/S1P3 receptors.
S1P-free and S1P-containing rHDL were prepared from the major HDL components (apoA-I, palmitoyloleoyl phosphatidylcholine (POPC) and cholesterol) using cholate dialysis [43] . (n ϭ 3) ; effects observed in S1P-enriched small, dense HDL 3b and 3c (annexin V binding was reduced by 23% and 9%, respectively) were weaker, consistent with their lower levels of enrichment; these effects were non-significant. As a result, the molar content of S1P in HDL used in the S1P enrichment experiments weakly negatively correlated with annexin V binding (r ϭ -0.38, P ϭ 0.008).
Ligation of S1P1/S1P3 receptors with a pharmacological inhibitor moderately attenuated the cytoprotective action of HDL 3c (-26%, P Ͻ 0.05). Indeed, after preincubation with the inhibitor, HDL 3c reduced apoptosis of HMEC-1 by 28 Ϯ 8% as compared to that in the absence of the inhibitor (38 Ϯ 13%; n ϭ 5). By contrast, ligation of S1P1/S1P3 receptors by Pertussis toxin did not affect the capacity of HDL 3c to protect HMEC-1 from oxLDL-induced apoptosis (data not shown). [46] . A conformation-dependent mechanism involving the accessibility of apoA-I might therefore underlie the elevated anti-apoptotic activity of small, dense HDL 3c; indeed, structural integrity of apoA-I is essential for HDL mediated cytoprotection [7] .
Discussion
As apoptosis of endothelial cells is a key feature of endothelial dysfunction and atherosclerotic plaque progression, it is highly
Mild oxLDL induces apoptosis primarily via its elevated content of lipid hydroperoxides and to a lesser degree oxysterols and other oxidized lipids [37] [18, 51] . Earlier studies which employed HPLC with UV detection [9] (less specific as compared to fluorescent detection used in later studies [18, 51] 
